Meibomian Gland Dysfunction
Pipeline by Development Stage
Competitive Landscape
11 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
Showing 15 of 16 trials with date data
Clinical Trials (16)
Total enrollment: 1,830 patients across 16 trials
Efficacy of Zylet vs. Lotemax for the Treatment of Ocular Surface Inflammation/MGD/Blepharitis
A Phase 3 Study to Evaluate AZR-MD-001 in Patients with Abnormal Meibomian Gland Function and Dry Eye Disease (DED)
Methods to Enhance AZR-MD-001 for Meibomian Gland Dysfunction (MGD)
Safety, Tolerability and Pharmacodynamics of AZR-MD-001 in Contact Lens Discomfort (CLD)
Evaluation of AZR-MD-001 in Patients With Meibomian Gland Dysfunction (MGD)
An Evaluation of AZR-MD-001 as Treatment for Meibomian Gland Dysfunction (MGD) or Contact Lens Discomfort (CLD)
A Multicenter Study Evaluating AZR-MD-001 in Patients With Meibomian Gland Dysfunction and Evaporative Dry Eye Disease (DED)
Study to Determine the Effect of Azasite on Corneal Surface Irregularity
A Study of AGN-195263 for the Treatment of Meibomian Gland Dysfunction
Evaluating Impact of Systane iLux on Dryness Symptoms and Wearing Time in Contact Lens Users
The Effect of Warm Compress Therapy Using the TearRestore Eyelid Warming Mask on Meibomian Gland Function
iLux Treatment for Meibomian Gland Dysfunction
Comparison Between iLux and LipiFlow in the Treatment of Meibomian Gland Dysfunction (MGD): A 12-month, Multicenter Study
Contact Lens Comfort Relative to Meibomian Gland Status
The Efficacy of an Ocular Emulsion in Meibomian Gland Dysfunction
Phase Legend
Key Insights
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.